Page 3 - செல்லுலார் நரம்பியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from செல்லுலார் நரம்பியல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In செல்லுலார் நரம்பியல் Today - Breaking & Trending Today

The Chinese Dreamers vs. the U.S. Hegemon

Do China and the US have fundamental goals that constitute a contradiction, that is, goals so profoundly at odds with one another that the goals cannot coexist? Unfortunately, the answer is yes. Such a contradiction means that one side must abandon its aims if a disastrous conflict is not to ensue. Which country should step […] ....

United States , Paul Wolfowitz , George Kennan , Stephen Wertheim , Johnv Walsh , Georgef Kennan , Henry Luce , Massachusetts Medical School , World Bank , Consortium News , Chinese Dream , Peoples Republic , Cold War , Wolfowitz Doctrine , Paul Wolfowitz Under Secretary , Planning Guidance , Dissident Voice , East Bay , Cellular Neuroscience , Massachusetts Medical , ஒன்றுபட்டது மாநிலங்களில் , ஜார்ஜ் கெநந் , ஸ்டீபன் வர்ட்‌ஹைம் , ஹென்றி லூஸ் , மாசசூசெட்ஸ் மருத்துவ பள்ளி , உலகம் வங்கி ,

Capsida Biotherapeutics Raises $140M in Series A Funding

Capsida Biotherapeutics Inc., a Thousand Oaks, CA-based biotechnology company using an adeno-associated virus (AAV) engineering and cargo development platform to develop tissue-targeted gene therapies for multiple types of diseases, raised $140m in Series A funding.
Backers included Versant Ventures and Westlake Village BioPartners, which together provided $50m. Capsida also announced a multi-year strategic collaboration and option agreement with AbbVie that provides $90m in up front and equity investment capital in addition to potential future option, development and commercial milestone payments. The collaboration is aimed at developing targeted gene therapies for three programs in serious neurodegenerative diseases.
Led by Robert Cuddihy, M.D., chief executive officer, Capsida provides an AAV engineering platform that generates capsids optimized to target specific tissue types and limits transduction of tissues and cell types that are not relevant to the target dise ....

Thousand Oaks , United States , Robert Cuddihy , Viviana Gradinaru , Chrissy Chen Institute For Neuroscience At Caltech , Capsida Biotherapeutics Inc , Heritage Medical Research Institute Investigator , Versant Ventures , Westlake Village Biopartners , Biological Engineering , Cellular Neuroscience , Chrissy Chen Institute , ஆயிரம் ஓக்ஸ் , ஒன்றுபட்டது மாநிலங்களில் , கிறிஸி சென் நிறுவனம் க்கு நரம்பியல் இல் கால்டெக் , பாரம்பரியம் மருத்துவ ஆராய்ச்சி நிறுவனம் புலனாய்வாளர் , பல்துறை முயற்சிகள் , உயிரியல் பொறியியல் , செல்லுலார் நரம்பியல் , கிறிஸி சென் நிறுவனம் ,

Capsida Biotherapeutics Debuts with $140 Million of Capital

Capsida Biotherapeutics Debuts with $140 Million of Capital
- Versant, Westlake Village BioPartners launch next-generation gene therapy company with $50 million Series A -
- Collaboration with AbbVie provides $90 million in up front and equity investment capital to create tissue-targeted gene therapies for three CNS disease targets -
News provided by
Share this article
Share this article
THOUSAND OAKS, Calif., April 29, 2021 /PRNewswire/ Versant Ventures and Westlake Village BioPartners today announced the emergence from stealth mode of Capsida Biotherapeutics Inc., a biotechnology company using an adeno-associated virus (AAV) engineering and cargo development platform to develop tissue-targeted gene therapies for multiple types of diseases. In addition to a $50 million Series A commitment from the two firms, Capsida also announced a multi-year strategic collaboration and option agreement with AbbVie that provides $90 million in up front and equity invest ....

Thousand Oaks , United States , Eric Karran , Los Angeles , Beth Seidenberg , Robert Cuddihy , Viviana Gradinaru , Capsida Biotherapeutics , Clare Ozawa , Chrissy Chen Institute For Neuroscience At Caltech , Capsida Biotherapeutics Inc , Heritage Medical Research Institute Investigator , Westlake Village Biopartners , Biological Engineering , Cellular Neuroscience , Chrissy Chen Institute , Vice President , Neuroscience Discovery , Greater Los Angeles , Village Biopartners , ஆயிரம் ஓக்ஸ் , ஒன்றுபட்டது மாநிலங்களில் , லாஸ் ஏஞ்சல்ஸ் , பெத் சீடன்பெர்க் , தெளிவு ஒஸாவ , கிறிஸி சென் நிறுவனம் க்கு நரம்பியல் இல் கால்டெக் ,

WholisticResearch Acquires Domain of Adherex Technologies Inc.

Share this article
Share this article
EASTBOURNE, England, April 28, 2021 /PRNewswire/ WholisticResearch, the fact-finding blog on rare nootropics and peptides, announced today that it had acquired the domain name previously owned by Adherex Technologies Inc. biopharmaceutical company, committed to discover and develop therapeutics for cancer and cognitive improvement.
The CEO of WholisticResearch shared, I believe that the domain of Adherex is a significant addition to our venture. This move can contribute to providing vendors and consumers with high-quality researched compounds synthesized in our UK labs.
This domain acquisition is a notable milestone for both companies as they share the same passion for providing a safer way to deal with cognitive issues and disorders. Together, WholisticResearch, combined with Adherex s promising scientific discoveries, more innovative and potent medical treatment is within our reach. ....

United States , United Kingdom , East Sussex , Jacob Kovacs , Life Sciences , Oregon Health Science University , Adherex Technologies Inc , Adherex Technologies , Sodium Thiosulfate , Oregon Health , Science University , Biological Chemistry , Metastasis Reviews , Molecular Membrane Biology , Cellular Neuroscience , House Flat , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , கிழக்கு சசெக்ஸ் , ஜாகோப் கோவ்யாக்ஸ் , வாழ்க்கை அறிவியல் , ஓரிகந் ஆரோக்கியம் அறிவியல் பல்கலைக்கழகம் , ஓரிகந் ஆரோக்கியம் , அறிவியல் பல்கலைக்கழகம் , உயிரியல் வேதியியல் , செல்லுலார் நரம்பியல் ,

University of Reading rat study could help treat dementia and epilepsy

The University of Reading
A POTENTIAL treatment for dementia and epilepsy has been revealed by Reading University in a new study using a rat s brain cells.
The research published in Scientific Reports on Wednesday, April 14, shows that treatments to reduce levels of hydrogen sulfide (H2S) in the brain may help to ward off damage caused by the gas.
By testing rat brain cells, the team of scientists from the University of Reading, University of Leeds and John Hopkins University in the USA found that H2S is involved in blocking a key brain cell gateway that helps the brain to communicate effectively. ....

United States , University Of Reading , University Of Leeds , Reading University , John Hopkins University , Scientific Reports , Mark Dallas , Associate Professor , Cellular Neuroscience , ஒன்றுபட்டது மாநிலங்களில் , பல்கலைக்கழகம் ஆஃப் ரீடிஂக் , பல்கலைக்கழகம் ஆஃப் லீட்ஸ் , ரீடிஂக் பல்கலைக்கழகம் , ஜான் ஹாப்கின்ஸ் பல்கலைக்கழகம் , அறிவியல் அறிக்கைகள் , குறி டல்லாஸ் , இணை ப்ரொஃபெஸர் , செல்லுலார் நரம்பியல் ,